EP1180027A4 - METHODS FOR PREVENTING HEART CIRCULAR DISORDERS IN CONNECTION WITH HEART CANAL INTERVENTIONS - Google Patents

METHODS FOR PREVENTING HEART CIRCULAR DISORDERS IN CONNECTION WITH HEART CANAL INTERVENTIONS

Info

Publication number
EP1180027A4
EP1180027A4 EP00908440A EP00908440A EP1180027A4 EP 1180027 A4 EP1180027 A4 EP 1180027A4 EP 00908440 A EP00908440 A EP 00908440A EP 00908440 A EP00908440 A EP 00908440A EP 1180027 A4 EP1180027 A4 EP 1180027A4
Authority
EP
European Patent Office
Prior art keywords
prevention
reduction
events associated
cardiovascular events
coronary intervention
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00908440A
Other languages
German (de)
English (en)
French (fr)
Other versions
EP1180027A1 (en
Inventor
Jeffrey R Granett
Neil H Shusterman
Prichard David C U
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of EP1180027A1 publication Critical patent/EP1180027A1/en
Publication of EP1180027A4 publication Critical patent/EP1180027A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP00908440A 1999-02-03 2000-02-02 METHODS FOR PREVENTING HEART CIRCULAR DISORDERS IN CONNECTION WITH HEART CANAL INTERVENTIONS Withdrawn EP1180027A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11846399P 1999-02-03 1999-02-03
US118463P 1999-02-03
PCT/US2000/002611 WO2000045810A1 (en) 1999-02-03 2000-02-02 Method for the prevention or reduction of cardiovascular events associated with coronary intervention

Publications (2)

Publication Number Publication Date
EP1180027A1 EP1180027A1 (en) 2002-02-20
EP1180027A4 true EP1180027A4 (en) 2004-11-17

Family

ID=22378760

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00908440A Withdrawn EP1180027A4 (en) 1999-02-03 2000-02-02 METHODS FOR PREVENTING HEART CIRCULAR DISORDERS IN CONNECTION WITH HEART CANAL INTERVENTIONS

Country Status (17)

Country Link
EP (1) EP1180027A4 (no)
JP (1) JP2002536326A (no)
KR (1) KR20010101933A (no)
CN (1) CN1338930A (no)
AR (1) AR022475A1 (no)
AU (1) AU2978500A (no)
BR (1) BR0007901A (no)
CA (1) CA2361578A1 (no)
CO (1) CO5160246A1 (no)
HU (1) HUP0200148A3 (no)
IL (1) IL144719A0 (no)
MX (1) MXPA01007833A (no)
NO (1) NO20013789L (no)
PL (1) PL349926A1 (no)
TR (1) TR200102262T2 (no)
WO (1) WO2000045810A1 (no)
ZA (1) ZA200106297B (no)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8097650B2 (en) * 2005-07-27 2012-01-17 The Trustees Of Columbia University In The City Of New York Method of treating a condition associated with phosphorylation of TASK-1

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998029104A2 (en) * 1996-12-30 1998-07-09 Kissei Pharmaceutical Co., Ltd. Use of 2-(3,4-dimethoxycinnamoyl)aminobenzoic acid for the manufacture of a medicament for the treatment or prevention of restenosis
EP0855387A1 (en) * 1995-09-07 1998-07-29 Kissei Pharmaceutical Co., Ltd. 2-acylaminobenzamide derivatives and preventive and remedy for diseases caused by the supermultiplication of vascular intimal cells

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2617407B2 (ja) * 1992-09-14 1997-06-04 キッセイ薬品工業株式会社 血管内膜細胞過剰増殖疾患の予防および治療剤

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0855387A1 (en) * 1995-09-07 1998-07-29 Kissei Pharmaceutical Co., Ltd. 2-acylaminobenzamide derivatives and preventive and remedy for diseases caused by the supermultiplication of vascular intimal cells
WO1998029104A2 (en) * 1996-12-30 1998-07-09 Kissei Pharmaceutical Co., Ltd. Use of 2-(3,4-dimethoxycinnamoyl)aminobenzoic acid for the manufacture of a medicament for the treatment or prevention of restenosis

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO0045810A1 *

Also Published As

Publication number Publication date
BR0007901A (pt) 2001-10-30
JP2002536326A (ja) 2002-10-29
MXPA01007833A (es) 2002-06-21
TR200102262T2 (tr) 2002-02-21
CO5160246A1 (es) 2002-05-30
CA2361578A1 (en) 2000-08-10
AU2978500A (en) 2000-08-25
EP1180027A1 (en) 2002-02-20
KR20010101933A (ko) 2001-11-15
HUP0200148A2 (hu) 2002-05-29
AR022475A1 (es) 2002-09-04
CN1338930A (zh) 2002-03-06
NO20013789L (no) 2001-09-28
HUP0200148A3 (en) 2003-06-30
WO2000045810A1 (en) 2000-08-10
ZA200106297B (en) 2002-07-31
NO20013789D0 (no) 2001-08-02
PL349926A1 (en) 2002-10-21
IL144719A0 (en) 2002-06-30

Similar Documents

Publication Publication Date Title
NZ514350A (en) Compositions and methods for effecting the levels of cholesterol
GB2352377B (en) Noise suppression method
GB2354240B (en) Method for the preparation of citalopram
HK1040266B (zh) 鈦合金及其製備方法
GB2354239B (en) Method for the preparation of citalopram
HK1048122B (zh) 製備西酞普蘭的方法
PL347492A1 (en) New esters derived from substituted phenyl-cyclohexyl compounds
HUP0203746A3 (en) Novel composition and method for stabilizing the same
AU5294100A (en) Method and compositions for treating the inflammatory response
PL351644A1 (en) Method and arrangement for the manufacture of lignocellulose-containing boards
HUP0200169A3 (en) Method for the preparation of citalopram
IL144719A0 (en) Method for the prevention or reduction of cardiovascular events associated with coronary intervention
AU2001275414A1 (en) Method for the prevention or reduction of cardiovascular events associated with coronary intervention
IL144721A0 (en) Method for the prevention or reduction of cardiovascular events associated with coronary intervention
AU2001243248A1 (en) Method for the prevention or reduction of vascular access dysfunction
SI1216038T1 (sl) Ramipril za preprecevanje kardiovaskularnih dogodkov
TW437347U (en) Shelving for suspension from rafters or the like
AU144457S (en) Pit component
ZA200007580B (en) Materials and methods for prevention or reduction of the severity of heartwater.
PL108457U1 (en) Metal furniture framework
TW376703U (en) Structure of the shelves of combination type
TW417610U (en) Structure improvement of the steel rim
AU145113S (en) Flange
TW371938U (en) Improvement of the basket
GB9905518D0 (en) Novel method and compound

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20010823

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI PAYMENT 20010823

A4 Supplementary search report drawn up and despatched

Effective date: 20041005

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20041103